ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    Voriconazole Associated Adverse Drug Events and Drug Monitoring in Lung Transplant Recipients

    C. Y. Luo1, R. G. Nador2, R. D. Levy2, J. Yee2, L. Wei2, N. Partovi1

    1Vancouver General Hospital, Vancouver, BC, Canada, 2University of British Columbia, Vancouver, BC, Canada

    *Purpose: Voriconazole is the drug of choice for prophylaxis and treatment of Aspergillus infection in lung transplant ( LTx) recipients. Voriconazole has a narrow therapeutic…
  • 2020 American Transplant Congress

    A Large Animal Model of Ex-Vivo Lung Perfusion as a Platform to Deliver Therapeutic Agents to Lungs Before Lung Transplant

    T. M. Egan1, B. Haithcock1, M. H. Ali1, J. W. Blackwell1, B. Masuodi1, S. Shipley2, T. Long3, A. Akerman1, S. Montgomery4, H. Yuan5, P. Stewart6, J. Potenziano7, C. Sekaran7, R. Fitch7

    1Surgery, UNC at Chapel Hill, Chapel Hill, NC, 2Department of Pathology and Laboratory Medicine, UNC at Chapel Hill, Chapel Hill, NC, 3Pathology and Laboratory Medicine,, UNC at Chapel Hill, Chapel Hill, NC, 4Pathology and Laboratory Medicine, UNC at Chapel Hill, Chapel Hill, NC, 5Radiology, UNC at Chapel Hill, Chapel Hill, NC, 6Gillings Global School of Public Health, UNC at Chapel Hill, Chapel Hill, NC, 7Mallinckrodt Pharmaceuticals, Hazelwood, MO

    *Purpose: Ex-vivo lung perfusion (EVLP) has been used to evaluate lung function before lung transplant (LT). We used EVLP to expose lungs recovered 6 hours…
  • 2020 American Transplant Congress

    Clinical and Demographic Factors Affecting Patient and Graft Survival in Pancreas Transplant Recipients: The Efispan Study

    P. Ventura-Aguiar1, M. Cabello2, I. Beneyto3, D. Navarro Cabello4, G. Tabernero5, A. Alonso6, J. Ruiz7, S. Llorente8

    1Nephrology and Kidney Transplantation, Hospital Clinic Barcelona, Barcelona, Spain, 2Department of Nephrology, Hospital Carlos Haya, Malaga, Spain, 3Department of Nephrology, Hospital La Fe, Valencia, Spain, 4Department of Nephrology, Hospital Reina Sofía, Cordoba, Spain, 5Department of Nephrology, Hospital Universitario de Salamanca, Salamanca, Spain, 6Department of Nephrology, Hospital Universitario de A Coruña, A Coruña, Spain, 7Department of Nephrology, Hospital Marqués de Valdecilla, Santander, Spain, 8Department of Nephrology, Hospital Virgen de la Arrixaca, Murcia, Spain

    *Purpose: Pancreas transplantation is an established treatment for diabetic patients with end-stage renal disease. Graft outcomes have improved in the last decades, but data regarding…
  • 2020 American Transplant Congress

    Long Term Liver Transplant Survivors

    M. Haberal1, E. Ayvazoglu Soy1, G. Moray1, F. Ozcay2, A. Torgay3

    1Department of General Surgery, Division of Transplantation, Baskent University, Ankara, Turkey, 2Pediatric Nephrology, Baskent University, Ankara, Turkey, 3Anaesthesia, Baskent University, Ankara, Turkey

    *Purpose: Few reports mentioned about long term survey. In this study, we aimed to report the outcomes of our long term LT survivors (LTS).*Methods: Our…
  • 2020 American Transplant Congress

    Cyclophilin-D Inhibition Mitigates Cardiac Allograft Ischemia-Reperfusion Injury and Rejection

    A. Qamar1, P. McLeod2, J. Jiang2, X. Huang2, A. M. Jevnikar2, Z. Zhang2

    1Pathology & Laboratory Medicine, University of Western Ontario, London, ON, Canada, 2London Health Sciences Center, London, ON, Canada

    *Purpose: The clinical relevance of ischemia-reperfusion injury (IRI) in the context of organ transplantation is well-established. IRI is associated with various forms of programmed cell…
  • 2020 American Transplant Congress

    Contamination of Acinar Cells Impairs Therapeutic Effect of Islet Transplantation Due to Induction of Inflammatory Reaction in Not Only Graft Islets but Also Hepatic Parenchyma

    K. Chinen, G. Yoshimatsu, N. Sakata, S. Kodama

    Regenerative Medicine and Transplantation, Fukuoka University, Fukuoka City, Japan

    *Purpose: Islet transplantation is a promising treatment option for type 1 diabetes. Edmonton protocol recommended that over 30 % purity of islets is essential for…
  • 2020 American Transplant Congress

    Intra-Lymph Node Injection of Microparticles Reprograms the Laminin Stromal Network to Prolong Allograft Survival

    C. M. Paluskievicz1, Y. Xiong1, W. Piao1, M. Willson-Shirkey1, H. Eppler2, C. M. Jewell2, J. S. Bromberg1

    1U Maryland, Baltimore, MD, Baltimore, MD, 2U Maryland, College Park, MD, College Park, MD

    *Purpose: Microparticles (MPs) carrying peptide antigen with immune signals can be directly delivered to lymph nodes (LNs) to induce pro-inflammatory or anti-inflammatory responses. We hypothesized…
  • 2020 American Transplant Congress

    Safety and Efficacy of Low Dose Rabbit Antithymocyte Globulin in Pediatric Renal Transplant Recipients

    V. K. Sigurjonsdottir1, L. Maestretti1, A. McGrath1, A. Gallo2, W. Concepcion2, P. Grimm1, A. Chaudhuri1

    1Pediatric Nephrology, Stanford University, Stanford, CA, 2Surgery - Multi-Organ Transplantation, Stanford University, Stanford, CA

    *Purpose: Currently there is no consensus among pediatric kidney transplant centers regarding the use and regimen for immunosuppressive induction therapy.The safety and effectiveness of reduced…
  • 2020 American Transplant Congress

    The Time is Now: Improving Waiting Times in Minority Populations

    L. Mendez-Castaner, L. Preczewski, M. Muldoon, A. Harshman, M. Goble, G. Guerra

    Miami Transplant Institute, Miami, FL

    *Purpose: A significant limiting factor to transplantation resides on waiting time based on blood type. Historically candidates in blood groups B and O experience higher…
  • 2020 American Transplant Congress

    Persistent Tertiary Hyperparathyroidism in the First Year after Kidney Transplantation is Associated with Calcium Phosphate Deposition in the Kidney Allograft

    R. S. Avasare1, N. K. Andeen2, M. Stack1, E. N. Dewey3, S. Rehman1, M. Shindo4, J. Y. Lim3

    1Nephrology & Hypertension, OHSU, Portland, OR, 2Pathology, OHSU, Portland, OR, 3Surgery, OHSU, Portland, OR, 4Otolaryngology, OHSU, Portland, OR

    *Purpose: To investigate risk factors for calcium phosphate deposition in the kidney allograft.*Methods: This is a single-institution, retrospective analysis of adult patients who underwent kidney…
  • « Previous Page
  • 1
  • …
  • 91
  • 92
  • 93
  • 94
  • 95
  • …
  • 223
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences